患者报告的心力衰竭患者健康的社会决定因素
Kenneth E Freedland1, Brian C Steinmeyer1, Judith A Skala1
1Washington University School of Medicine St. Louis MO USA.
Journal of the American Heart Association
|May 13, 2025
概括
一个新的健康社会决定因素 (SDOH) 患者访谈表可靠地评估心力衰竭患者患者报告的因素. 该研究确定了两种不同的SDOH模式,有助于增加健康负担.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 健康的社会决定因素 (SDOH) 显著影响医疗保健和患者的结果.
- 缺乏在临床环境中评估SDOH的结构化工具,阻碍了研究和患者护理.
- 这项研究解决了在心力衰竭患者中评估SDOH的可靠仪器的需求.
研究的目的:
- 为了评估新开发的健康社会决定因素 (SDOH) 患者访谈表格的可靠性和有效性.
- 在被诊断为心力衰竭的患者中调查SDOH的患病率和模式.
主要方法:
- 该SDOH患者访谈表格被用于最近住院的367名心力衰竭患者.
- 采访被记录下来,其中50人被随机选择用于interrater可靠性分析.
- 分析了数据以确定形式的可靠性和SDOH与临床因素之间的关联.
主要成果:
- SDOH患者采访表显示了高interrater可靠性 (类别为100%,项目为k ≥0.94).
- 较高的SDOH负担与年轻的年龄,较低的收入,增加的纽约心脏协会等级和更高的BMI相关.
- 两个主要的SDOH模式出现了:童年虐待导致成人剥夺,以及损失,财务压力和照顾困难的压力.
结论:
- SDOH患者面试表格是评估患者报告的SDOH在心力衰竭人群中的可靠工具.
- 该仪器适用于临床和研究应用,有可能在其他患者群体中得到更广泛的应用.
- 该研究确定了社会决定因素的独特,有影响力的模式,这些因素有助于增加患者健康负担.
更多相关视频
04:24A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
11.5K
10:21Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test
Published on: September 22, 2023
538
相关概念视频
01:23Assessment of the Cardiovascular System I: Subjective Data
256
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
256
01:17Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
01:22Heart Failure Drugs: Diuretics
313
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
313
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
356
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
356
01:22Heart Failure Drugs: β-Blockers
300
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
300
01:21Dimensions of Health and Illness
7.0K
The factors influencing the health-illness continuum can be internal or external and may or may not be under conscious control. They are related to the following eight human dimensions, and each dimension is interrelated to one other.
7.0K